Peng D, Hu T, Soutto M, Belkhiri A, Zaika A, El-Rifai W
Eli Lilly, the makers of Zepbound, gained FDA approval for its drug orforglipron, sold under the brand name Foundayo, on April 1, 2026, following Novo Nordisk, which received approval for the Wegovy pill in December 2025
Less common side effects included skin tingling and a temporary increase in heart rate during the first 24 weeks of treatment
E.GouinT.KoelmansA
placebo) added to risperidone was associated with greater improvement in irritability, lethargy/social withdrawal, stereotypic behavior, and hyperactivity in children with ASD
Whether you're interested in Semaglutide for weight loss, professional hormone healing services, or revitalizing your skin, our team of experts is here to support you every step of the way